Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

被引:36
|
作者
Kristensen, Soren L. [1 ,2 ]
Jhund, Pardeep S. [1 ]
Kober, Lars [3 ]
Preiss, David [1 ]
Kjekshus, John [4 ]
McKelvie, Robert S. [5 ]
Zile, Michael R. [6 ,7 ]
Anand, Inder S. [8 ,9 ]
Wikstrand, John [10 ]
Wedel, Hans [11 ]
Komajda, Michel [12 ,13 ]
Carson, Peter E. [14 ,15 ]
Cleland, John G. F. [16 ,17 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[5] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[6] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden
[11] Nord Sch Publ Hlth, Gothenburg, Sweden
[12] Univ Paris 06, Hosp Pitie Salpetriere, Paris, France
[13] Inst ICAN, Paris, France
[14] Georgetown Univ, Washington, DC USA
[15] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[16] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[17] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England
关键词
Heart failure; Clinical trials; HF-PEF; HF-REF; Mortality; ROSUVASTATIN; TRIAL; PROGRESSION; IRBESARTAN; DESIGN; CORONA;
D O I
10.1002/ejhf.211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF). Methods and resultsWe studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and 31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality 30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality 30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29). ConclusionsIn patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [21] Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction
    Butler, Javed
    Yang, Mei
    Manzi, Massimiliano Alfonzo
    Hess, Gregory P.
    Patel, Mahesh J.
    Rhodes, Thomas
    Givertz, Michael M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 935 - 944
  • [22] Contemporary Trends in Heart Failure with Reduced and Preserved Ejection Fraction after Myocardial Infarction: A Community Study
    Gerber, Yariv
    Weston, Susan A.
    Berardi, Cecilia
    McNallan, Sheila
    Redfield, Margaret M.
    Roger, Veronique L.
    CIRCULATION, 2013, 127 (12)
  • [23] Exercise limitations in heart failure with reduced and preserved ejection fraction
    Poole, David C.
    Richardson, Russell S.
    Haykowsky, Mark J.
    Hirai, Daniel M.
    Musch, Timothy I.
    JOURNAL OF APPLIED PHYSIOLOGY, 2018, 124 (01) : 208 - 224
  • [24] Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction EMPEROR-Preserved Trial
    Packer, Milton
    Butler, Javed
    Zannad, Faiez
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Carson, Peter
    Anand, Inder
    Doehner, Wolfram
    Haass, Markus
    Komajda, Michel
    Miller, Alan
    Pehrson, Steen
    Teerlink, John R.
    Schnaidt, Sven
    Zeller, Cordula
    Schnee, Janet M.
    Anker, Stefan D.
    CIRCULATION, 2021, 144 (16) : 1284 - 1294
  • [25] Outcomes in Patients With Heart Failure With Preserved Ejection Fraction It Is More Than the Heart
    Kitzman, Dalane W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) : 1006 - 1007
  • [26] Prognostic Value of Depressive Symptoms for Cardiovascular Events in Female Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
    Zhao, Hengli
    Jiang, Jiaxue
    Zhong, Guoheng
    Peng, You
    Wen, Yihong
    Liang, Yu
    Shan, Zhixin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (09):
  • [27] Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
    Yang, Mingming
    Kondo, Toru
    Jhund, Pardeep S.
    Alcocer-Gamba, Marco Antonio
    Borleffs, C. Jan Willem
    Chiang, Chern-En
    Comin-Colet, Josep
    Desai, Akshay S.
    Dobreanu, Dan
    Drozdz, Jaroslaw
    Han, Yaling
    Janssens, Stefan P.
    Katova, Tzvetana
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Merkely, Bela
    Pham, Vinh Nguyen
    Thierer, Jorge
    Vaduganathan, Muthiah
    Verma, Subodh
    Solomon, Scott D.
    Mcurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (08) : 1788 - 1803
  • [28] Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach
    van Essen, Bart J.
    Tharshana, Ganash N.
    Ouwerkerk, Wouter
    Yeo, Poh Suan Daniel
    Sim, David
    Jaufeerally, Fazlur
    Ong, Hean Yee
    Ling, Lieng Hsi
    Soon, Dinna Kar Nee
    Lee, Shao Guang Sheldon
    Leong, Gerard
    Loh, Seet Yoong
    San Tan, Ru
    Ramachandra, Chrishan J.
    Hausenloy, Derek J.
    Liew, Oi Wai
    Chong, Jenny
    Voors, Adriaan A.
    Lam, Carolyn S. P.
    Richards, A. Mark
    Tromp, Jasper
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 841 - 850
  • [29] Characteristics and Outcomes of Worsening Left Ventricular Ejection Fraction in Heart Failure Patients With Preserved Ejection Fraction.
    Oikawa, Masayoshi
    Yoshihisa, Akiomi
    Ichijyo, Yasuhiro
    Kiko, Takatoyo
    Kimishima, Yusuke
    Sato, Yu
    Kanno, Yuki
    Takiguchi, Mai
    Yokokawa, Tetsuro
    Abe, Satoshi
    Misaka, Tomofumi
    Sato, Takamasa
    Kobayashi, Atsushi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Ishida, Takafumi
    Takeishi, Yasuchika
    CIRCULATION, 2018, 138
  • [30] Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
    Henry, John Aaron
    Couch, Liam S.
    Rider, Oliver J.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)